Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Odyssey Therapeutics
Focused on transforming lives of patients with immune dysfunctions and cancer
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Company
Organization
B2X
B2B
CEO
Gary D. Glick
Company Operating Status
Active
Country
Germany
0
United States
0
Crunchbase URL
crunchbase.com/organiz...ics-29e0
Email Address
media@odysseytx.com
Founder
Gary D. Glick
0
David Pompliano
0
Full Address
1350 Highland Drive, Suite A, Ann Arbor, MI 48108
0
301 Binney Street, Cambridge, MA 02142
0
Industriepark Höchst, G875, 65926 Frankfurt am Main, Germany
0
Industry
Healthcare
Cancer
Cancer immunotherapy
Therapeutics
Technology
Biology
Biotechnology
Internal medicine
Medicine
Oncology
•••
Investors
T. Rowe Price
General Catalyst
Creacion Ventures
SR One
Foresite Capital
OrbiMed
Colt Ventures
Logos Capital
Woodline Partners
Catalio Capital Management
•••
Latest Funding Round Date
October 13, 2022
Latest Funding Round Amount (USD)
168,000,000
Latest Funding Type
Series B Round
LinkedIn URL
@company/odyssey-tx
Location
Germany
Cambridge, Massachusetts
0
Phone Number
+16178659628
0
Total Funding Amount (USD)
386,000,000
Twitter URL
@odyssey_tx
Official Website
odysseytx.com
Find more companies like Odyssey Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE